• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    US Medical Devices Ishares ETF (NY: IHI )

    59.54 +0.10 (+0.17%)
    Official Closing Price Updated: 8:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about US Medical Devices Ishares ETF

    < Previous 1 2 Next >
    What Does the Economic Modern Family Say Now?
    Considering where the Economic Modern Family was just a few weeks ago, clearly euphoria has spread since the election. 
    Via Talk Markets
    Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
    There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
    Via Talk Markets
    Can You Lose Money Investing in ETFs? 3 Things to Know.
    ETFs can be safe yet powerful investments. But there are still risks involved. 
    Via The Motley Fool
    Topics ETFs
    Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Details
    Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings. 
    Via Benzinga
    CME Group, Chubb, Berkshire Hathaway And More On CNBC's 'Final Trades'
    Kevin Simpson of Capital Wealth Planning said CME Group yields a 4.5% dividend and trades at a forward PE of 21, which is pretty low. 
    Via Benzinga
    ETF Winners Of Q2 Earnings: 4 Must-See Charts
    This article lists four ETFs from different sectors that have gained from strong earnings despite the market volatility. 
    Via Talk Markets
    Topics ETFs
    Large Cap Biopharma And Healthcare, A Port In A Storm
    Healthcare and biopharma show nice gains in a volatile week. 
    Via Talk Markets
    Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
    You don't need to be a stock market expert to earn above-average returns. 
    Via The Motley Fool
    The All-Weather ETF Trifecta: 3 Funds to Buy and Hold Forever
    These long-term ETfs to buy and hold offer exposure to the best-performing market segments with improved diversification to boot. 
    Via InvestorPlace
    Topics ETFs
    The 3 Best ETFs to Buy in May 2024
    The best ETFs to buy in May capture sectors on sale and help build a well-rounded, diversified portfolio for long-term investors. 
    Via InvestorPlace
    Topics ETFs
    April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
    Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    3 ETFs That Could Turn Your Portfolio Into a Tech Powerhouse
    Staking your tech holdings on a few mega-caps isn't the wisest move; instead, diversify your holdings across these top tech ETFs. 
    Via InvestorPlace
    Topics ETFs
    Healthcare Stocks Are Looking Better But What About Biotech?
    Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. 
    Via Talk Markets
    Biotech And Medtech Portfolio Notes On A Fed Day
    The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024
    Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. 
    Via Talk Markets
    3 Thematic Growth ETFs to Load Up on Right Now
    These three thematic ETFs could be potent growth vehicles in years to come. 
    Via The Motley Fool
    Topics ETFs
    Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
    Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
    Via Investor's Business Daily
    Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
    The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
    Via Talk Markets
    Topics Economy
    Exposures Economy
    Elon Musk-Owned Neuralink's Brain Implant Could Fetch Over $220M Revenue In ALS Patients By 2030, Says Ark Analyst
    Neuralink's N1 implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention. 
    Via Benzinga
    Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns
    Via Benzinga
    Topics ETFs
    As Isreal-Palestine Conflict Escalates, Gold Ticks Up - ETF Winners And Losers: Medium-Cap Returns
    Via Benzinga
    Topics ETFs
    5 Sector ETFs To Fight Sticky Inflation
    The annual inflation rate in the United States accelerated for a second straight month to 3.7% in August from 3.2% in July. We suggest a few sector ETFs that can be worth investing in at a time of... 
    Via Talk Markets
    Topics ETFs Economy
    Exposures Interest Rates
    Healthcare Playbook Revisited - Growth Plus Value
    Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. 
    Via Talk Markets
    Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
    It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
    Via Talk Markets
    Topics ETFs
    Exposures COVID-19
    Big Weeks Ahead For MedTech And Life Science Stocks
    It’s a big week for earnings that may change the trajectory of the rally but more than likely will continue the rotation into different sectors. 
    Via Talk Markets
    Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
    Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
    Via Talk Markets
    Worried About U.S.-China Relations? Buy These 2 ETFs.
    These funds focus on U.S.-based companies in relatively stable industries. 
    Via The Motley Fool
    Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
    A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers. 
    Via Talk Markets
    Healthcare Sector Update: MedTech Trending Up
    Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market. 
    Via Talk Markets
    April Is Busting Out For Healthcare And Biotech
    Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend. 
    Via Talk Markets
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.